Wedbush Securities’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,210
Closed -$216K 1207
2024
Q1
$216K Buy
+5,210
New +$218K 0.01% 1050
2023
Q4
Sell
-7,445
Closed -$291K 1086
2023
Q3
$291K Buy
7,445
+2,449
+49% +$97.5K 0.01% 742
2023
Q2
$203K Sell
4,996
-7
-0.1% -$288 0.01% 923
2023
Q1
$209K Sell
5,003
-180
-3% -$7.57K 0.01% 920
2022
Q4
$226K Buy
+5,183
New +$220K 0.01% 852

Other funds holding BME

Wedbush Securities's BME Position: Q2 2024 in Review

Wedbush Securities sold out of BlackRock Health Sciences Trust (BME) in Q2 2024, closing a stake of 5,210 shares — an estimated $216K sold.

Wedbush Securities first reported a position in BME in Q4 2022 and held it in 5 quarters. The position peaked at $291K in Q3 2023. 69 funds tracked by Wall St. Rank hold BME as of Q2 2024.

  • Wedbush Securities reported no remaining BlackRock Health Sciences Trust position as of Q2 2024 after selling out during the quarter.
  • Wedbush Securities sold 5,210 BlackRock Health Sciences Trust shares in Q2 2024, an estimated $216K.
  • Wedbush Securities first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 5 quarters.
  • Wedbush Securities's BlackRock Health Sciences Trust position peaked at $291K in Q3 2023.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2024.

Based on Wedbush Securities's 13F filing for Q2 2024, filed 7 Aug 2024.